Analysis of Biomarkers in Systemic Juvenile Idiopathic Arthritis Patients On Canakinumab Therapy.

被引：0

作者：

Wulffraat, Nico ^{[1
]}

Brunner, Hermine I. ^{[2
]}

Ruperto, Nicolino ^{[1
]}

Quartier, Pierre ^{[3
]}

Brik, Riva ^{[1
]}

McCann, Liza ^{[1
]}

Ozdogan, Huri ^{[1
]}

Rutkowska-Sak, Lidia ^{[1
]}

Schneider, Rayfel ^{[2
]}

Gerloni, Valeria ^{[1
]}

Harel, Liora ^{[1
]}

Hilario, Maria ^{[2
]}

Houghton, Kristin ^{[2
]}

Joos, Rik ^{[1
]}

Kingsbury, Daniel ^{[2
]}

Brachat, Arndt ^{[4
]}

Bek, Stephan ^{[4
]}

Schumacher, Martin ^{[4
]}

Valentin, Marie-Anne ^{[4
]}

Nirmala, N. R. ^{[5
]}

Gram, Hermann ^{[4
]}

Abrams, Ken

Martini, Alberto ^{[1
]}

Lovell, D. J. ^{[6
]}

机构：

[1] Paediat Rheumatol Int Trials Org PRINTO, Genoa, Italy

[2] Pediat Rheumatol Collaborat Study Grp PRCSG, Cincinnati, OH USA

[3] Necker Enfants Malades Hosp, Paris, France

[4] Novartis Inst Biomed Res, Basel, Switzerland

[5] Novartis Inst Biomed Res, Cambridge, MA USA

[6] Cincinnati Childrens Hosp, Cincinnati, OH USA

来源：

ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

761

引用

页码：S328 / S328

页数：1

共 50 条

[1] Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis
Sun, Haiying
Van, Linh M.
Floch, David
Jiang, Xuemin
Klein, Ulf R.
Abrams, Ken
Sunkara, Gangadhar
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (12): : 1516 - 1527
[2] Tapering canakinumab in systemic juvenile idiopathic arthritis
Thorley, Jennifer
[J]. LANCET RHEUMATOLOGY, 2020, 2 (10): : E593 - E593
[3] Multiplex Serum Biomarker Analysis before and during Therapy with Canakinumab in Patients with Systemic Juvenile Idiopathic Arthritis
Hinze, Tanja
Kessel, Christoph
Hinze, Claas
Seibert, Julia
Gram, Hermann
Foell, Dirk
[J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
[4] Canakinumab (Ilaris) for Systemic Juvenile Idiopathic Arthritis
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1423): : 65 - 66
[5] Canakinumab for the treatment of systemic juvenile idiopathic arthritis
Grom, Alexei A.
[J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (11) : 1427 - 1435
[6] PReS-FINAL-2156: Analysis of gene expression and inflammation biomarkers in systemic juvenile idiopathic arthritis (SJIA) patients on canakinumab therapy
N Nirmala
N Wulffraat
H Brunner
P Quartier
R Brik
L Mccann
H Ozdogan
L Rutkowska-Sak
R Schneider
V Gerloni
L Harel
M Terreri
K Houghton
R Joos
D Kingsbury
J Lopez-Benitez
S Radominski
A Brachat
S Bek
M Schumacher
M Valentin
H Gram
K Abrams
A Martini
N Ruperto
D Lovell
[J]. Pediatric Rheumatology, 11 (Suppl 2)
[7] MAINTENANCE OF EFFICACY BY CANAKINUMAB TREATMENT IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS
Wulffraat, N. M.
Ruperto, N.
Brunner, H. I.
Oliveira, S.
Uziel, Y.
Nistala, K.
Cimaz, R.
Ferrandiz, M. A.
Flato, B.
Gamir, M. L.
Kone-Paut, I.
Gaillez, C.
Lheritier, K.
Abrams, K.
Martini, A.
Lovell, D. J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 130 - 130
[8] CHANGES IN GENE EXPRESSION AND INFLAMMATORY PROTEINS IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS PATIENTS ON CANAKINUMAB THERAPY
Brachat, A.
Grom, A.
Wulffraat, N.
Brunner, H.
Quartier, P.
Brik, R.
McCann, L.
Ozdogan, H.
Rutkowska-Sak, L.
Schneider, R.
Gerloni, V.
Harel, L.
Terreri, M.
Houghton, K.
Joos, R.
Kingsbury, D.
Lopez-Benitez, J.
Bek, S.
Schumacher, M.
Valentin, M.
Gram, H.
Abrams, K.
Martini, A.
Ruperto, N.
Lovell, D.
Nirmala, N.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 62 - 62
[9] Canakinumab for the treatment of active systemic juvenile idiopathic arthritis
Orrock, Janet E.
Ilowite, Norman T.
[J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (08) : 1015 - 1024
[10] Canakinumab treatment shows maintained efficacy in systemic juvenile idiopathic arthritis patients
NM Wulffraat
N Ruperto
HI Brunner
S Oliveira
Y Uziel
K Nistala
R Cimaz
MA Ferrandiz
B Flato
M Gamir
I Kone-Paut
C Gaillez
K Lheritier
K Abrams
A Martini
D Lovell
[J]. Pediatric Rheumatology, 12 (Suppl 1)

← 1 2 3 4 5 →